Browse result page of THPdb

The total number entries retrieved from this search are 61

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
ID1005	ThPPIDTh1002	NameCetuximab	Peptide SequenceHeavy chain:QVQLKQSG Full view	Length243	Functional ClassificationIIIc	DiseaseCancer	BrandErbitux	CompanyImClone Systems Inc	Physical AppearanceSterile, clear, colorless liquid of pH 7.0-7.4, which may contain a small amount of easily visible, white, amorphous cetuximab particulates	Route of AdministartionIntravenous infusion	CategoryAntineoplastic Agents	TargetEpidermal growth factor receptor,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
ID1025	ThPPIDTh1004	NameDenileukin diftitox	Peptide SequenceMGADDVVDSSKSFVMENFSS Full view	Length255	Functional ClassificationIIb	DiseaseCancer	BrandOntak	CompanySeragen Inc	Physical AppearanceSterile, white, preservative-free, lyophilized powder.	Route of AdministartionIntravenous(IV) administration	CategoryAntineoplastic Agents	TargetInterleukin-2 receptor subunit alpha,Interleukin-2 receptor subunit beta,Cytokine receptor common subunit gamma
ID1038	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandEligard	CompanyAtrix Labs/QLT In	Physical AppearanceSuspension	Route of AdministartionSubcutaneous Injection	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1039	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandEnantone	CompanyTakeda	Physical AppearanceSolution	Route of AdministartionInjection	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1040	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandLeuplin	CompanyTakeda	Physical AppearanceN.A.	Route of AdministartionInjection	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1041	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandLeuProMaxx	CompanyBaxter/Teva	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1042	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandLeupromer	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionInjection	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1043	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandLupron	CompanyAbbott/TAP Pharmaceuticals	Physical AppearanceN.A.	Route of AdministartionInjection	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1044	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandLutrate	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1045	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandMemryte	CompanyCuraxis	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1046	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandProstap 3	CompanyTakeda UK Limited	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1047	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandProstap SR	CompanyTakeda UK Limited	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1048	ThPPIDTh1007	NameLeuprolide	Peptide SequencePHWSYLLR Full view	Length8	Functional ClassificationIIa	DiseaseCancer	BrandViadur	CompanyBayer AG	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists	TargetGonadotropin-releasing hormone receptor
ID1142	ThPPIDTh1020	NameAsparaginase	Peptide SequenceQMSLQQELRYIEALSAIVET Full view	Length255	Functional ClassificationIc	DiseaseCancer	BrandElspar	CompanyMerck & Co. Inc	Physical AppearanceLyophilized plug or powder	Route of AdministartionIntravenous or Intramuscular. Intravenous method dose has higher risk of allergic reaction, so often a test dose is given first.	CategoryAntineoplastic Agents	TargetL-asparagine
ID1145	ThPPIDTh1021	NameThyrotropin Alfa	Peptide SequenceAlpha chain:APDVQDC< Full view	Length204	Functional ClassificationIV	DiseaseCancer	BrandThyrogen	CompanyGenzyme Inc	Physical AppearanceLyophilized powder	Route of AdministartionIntramuscular preferably the buttocks	CategoryDiagnostic Agents	TargetThyrotropin receptor
ID1242	ThPPIDTh1033	NameOprelvekin	Peptide SequenceGPPPGPPRVSPDPRAELDST Full view	Length177	Functional ClassificationIb	DiseaseCancer/Haemetological	BrandNeumega	CompanyGenetics Institute Inc	Physical AppearanceSterile, lyophilized powder	Route of AdministartionSubcutaneous injection	CategoryCoagulants and Thrombotic Agents, Anti-neoplastic agents	TargetInterleukin-11 receptor subunit alpha
ID1246	ThPPIDTh1034	NamePalifermin	Peptide SequenceSYDYMEGGDIRVRRLFCRTQ Full view	Length140	Functional ClassificationIb	DiseaseCancer	BrandKepivance	CompanyAmgen Inc	Physical AppearanceSterile, lyophilized powder	Route of AdministartionIntravenous infusion	CategoryAnti-Mucositis Agents	TargetFibroblast growth factor receptor 2,Neuropilin-1,Fibroblast growth factor receptor 1,Fibroblast growth factor receptor 4,Fibroblast growth factor receptor 3,Basement membrane-specific heparan sulfate proteoglycan core protein
ID1257	ThPPIDTh1036	NameAldesleukin	Peptide SequenceMAPTSSSTKKTQLQLEHLLL Full view	Length134	Functional ClassificationIb	DiseaseCancer/Infectious	BrandProleukin	CompanyChiron Corp	Physical AppearanceSterile, white to off-white, lyophilized cake	Route of AdministartionIntravenous administration	CategoryAntineoplastic Agents, Anti-HIV agents	TargetInterleukin-2 receptor subunit beta,Interleukin-2 receptor subunit alpha,Cytokine receptor common subunit gamma
ID1337	ThPPIDTh1048	NamePegaspargase	Peptide SequenceMEFFKKTALAALVMGFSGAA Full view	Length255	Functional ClassificationIc	DiseaseCancer	BrandOncaspar	CompanyEnzon Inc	Physical AppearanceSolution	Route of AdministartionIntravenous or Intramuscular administration	CategoryAntineoplastic Agents	TargetL-asparagine
ID1341	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandAvonex	CompanyBiogen Inc	Physical AppearanceLyophilized powder vial, Sterile liquid as single used prefilled syringe and also available as single use prefilled autoinjector.	Route of AdministartionIntramuscular Injection	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1342	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandBetaferon	CompanyBayer	Physical AppearancePowder and solvent that are made upto make solution.	Route of AdministartionSubcutaneous Injection	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1343	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandBetaseron	CompanyMerck	Physical AppearanceSterile, white to off-white powder	Route of AdministartionSubcutaneous Injection	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1344	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandBlastoferon	CompanySidus	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1345	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandExtavia	CompanyNovartis	Physical AppearanceSterile, white to off-white powder	Route of AdministartionSubcutaneous Injection	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1346	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandRebif	CompanyMerck	Physical AppearanceSterile solution in a prefilled syringe or REBIF Rebidose autoinjector	Route of AdministartionSubcutaneous Injection	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1385	ThPPIDTh1061	NameTrastuzumab	Peptide SequenceLight chain 1: DIQMT Full view	Length1364	Functional ClassificationIIa	DiseaseCancer	BrandHerceptin	CompanyGenentech	Physical AppearanceSterile, white to pale yellow, preservative-free lyophilized powder	Route of Administartion Intravenous administration	CategoryAntineoplastic Agents	TargetInsulin receptor,Insulin-like growth factor 1 receptor,Insulin-degrading enzyme,HLA class II histocompatibility antigen, DQ alpha 2 chain,HLA class II histocompatibility antigen, DQ beta 1 chain,Retinoblastoma-associated protein,Cathepsin D,Carboxypeptidase E,Neuroendocrine convertase 2,Neuroendocrine convertase 1,Protein NOV homolog,Low-density lipoprotein receptor-related protein 2,Insulin-like growth factor-binding protein 7,Synaptotagmin-like protein 4
ID1389	ThPPIDTh1062	NameRituximab	Peptide SequenceHeavy Chain: QVQLQQP Full view	Length664	Functional ClassificationIIa	DiseaseCancer/Immunological	BrandRituxan	CompanyBiogen Idec Inc., and Genentech USA, Inc	Physical AppearanceSterile, clear, colorless, preservative-free liquid concentrate	Route of Administartion Intravenous administration	CategoryAntineoplastic Agents, Immunologic Factors and Antirheumatic Agents	TargetB-lymphocyte antigen CD20,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c, Receptor tyrosine-protein kinase erbB-2,Epidermal growth factor receptor,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor I
ID1406	ThPPIDTh1066	NameIbritumomab	Peptide SequenceHeavy Chain: QAYLQQS Full view	Length652	Functional ClassificationIIb	DiseaseCancer	BrandZevalin	CompanySpectrum Pharmaceuticals	Physical AppearanceClear, colorless, sterile, pyrogen-free, preservative-free solution that may contain translucent particles.	Route of AdministartionIntravenous infusion	CategoryN.A.	TargetDigoxin
ID1412	ThPPIDTh1068	NameTositumomab	Peptide SequenceHeavy Chain 1: QAYLQ Full view	Length1351	Functional ClassificationIIb	DiseaseCancer	BrandBexxar	CompanyGalaxo Smith Kline	Physical AppearanceSterile, pyrogen-free, clear to opalescent, colorless to slightly yellow, preservative-free solutionÂÂÂ	Route of AdministartionIntravenous(IV) administration	CategoryN.A.	TargetBacterial outer membrane,Lipoteichoic acid synthesis
ID1431	ThPPIDTh1073	NameAlemtuzumab	Peptide SequenceHeavy Chain 1: QVQLQ Full view	Length2839	Functional ClassificationIIa	DiseaseCancer	BrandCAMPATH	CompanyGenzyme Corporation	Physical AppearanceSterile, clear, colorless, isotonic solution (pH 6.8-7.4)	Route of AdministartionIntravenous infusion	CategoryN.A.	TargetN.A.
ID1432	ThPPIDTh1073	NameAlemtuzumab	Peptide SequenceHeavy Chain 1: QVQLQ Full view	Length2389	Functional ClassificationIIa	DiseaseCancer	BrandLEMTRADA	CompanyGenzyme Corporation	Physical AppearanceLEMTRADA is a sterile, clear and colorless to slightly yellow, solution (pH 7.2±0.2) for infusion.	Route of AdministartionIntravenous infusion	CategoryNA	TargetNA
ID1435	ThPPIDTh1075	NameCapromab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIV	DiseaseCancer	BrandProstaScint	CompanyJazz Pharmaceuticals, Inc.	Physical AppearanceSterile, pyrogen-free, clear, colorless solution that may contain some translucent particles.	Route of AdministartionIntravenous injection	CategoryIndicators, Reagents and Diagnostic Agents	TargetCAMPATH-1 antigen,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
ID1470	ThPPIDTh1092	NameArcitumomab	Peptide SequenceHeavy chain 1EVKLVES Full view	Length1310	Functional ClassificationIIb	DiseaseCancer	BrandCEA-Scan	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryDiagnostic Agents	TargetVascular endothelial growth factor A,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c, Carcinoembryonic antigen-related cell adhesion molecule 1
ID1474	ThPPIDTh1094	NamePanitumumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseCancer	BrandVectibix	CompanyAmgen Inc	Physical AppearanceSterile, colorless, pH 5.6 to 6.0 liquid for intravenous (IV) infusion, which may contain a small amount of visible translucent-to-white, amorphous, proteinaceous, panitumumab particulates	Route of AdministartionN.A.	CategoryN.A.	TargetEpidermal growth factor receptor
ID1533	ThPPIDTh1112	NameNatural Alpha Interferon Or Multiferon	Peptide SequenceInteferon alpha-1: Full view	Length997	Functional ClassificationIIa	DiseaseCancer/Infectious	BrandIntron/ Roferon-A	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionSubcutaneous injection, Intravenous injection, Intramuscular injection	CategoryN.A.	TargetN.A.
ID1548	ThPPIDTh1117	NameIpilimumab	Peptide SequenceHeavy chain: QVQLVES Full view	Length663	Functional ClassificationIIIc	DiseaseCancer	BrandYERVOY	CompanyBristol-Myers Squibb	Physical AppearanceSterile, preservative-free, clear to slightly opalescent, colorless to pale-yellow solution	Route of AdministartionN.A.	CategoryAntineoplastic Agents and Monoclonal antibodies	TargetCytotoxic T-lymphocyte protein 4
ID1560	ThPPIDTh1121	NamePertuzumab	Peptide Sequencelight chain DIQMTQSP Full view	Length664	Functional ClassificationIIIc	DiseaseCancer	BrandPerjeta	CompanyGenentech	Physical AppearanceSterile, clear to slightly opalescent, colorless to pale brown liquid	Route of AdministartionIntravenous infusion	CategoryMonoclonal antibodies	TargetReceptor tyrosine-protein kinase erbB-2
ID1600	ThPPIDTh1127	NameBuserelin	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIIc	DiseaseCancer/Hormonal	BrandSuprecur (Nasal Spray Solution)	CompanySanofi-Aventis	Physical Appearance150 micrograms Nasal Spray Solution	Route of AdministartionNasal spray	CategoryN.A.	TargetLutropin-choriogonadotropic hormone receptor,Gonadotropin-releasing hormone receptor
ID1601	ThPPIDTh1127	NameBuserelin	Peptide SequencepGlu-His-Trp-Ser-Tyr Full view	Length9	Functional ClassificationIIIc	DiseaseCancer/Hormonal	BrandSuprecur (injection)	CompanySanofi-Aventis	Physical Appearance1mg/ml Injection	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetLutropin-choriogonadotropic hormone receptor,Gonadotropin-releasing hormone receptor
ID1604	ThPPIDTh1130	NameBrentuximab Vedotin	Peptide SequenceHeavy chain:QIQLQQSG Full view	Length664	Functional ClassificationIIb	DiseaseCancer	BrandAdcetris	CompanySeattle Genetics	Physical AppearanceSterile, white to off-white, preservative-free lyophilized cake or powder in single-use vials.	Route of AdministartionIntravenous infusion	CategoryN.A.	TargetTumor necrosis factor receptor superfamily member 8
ID1615	ThPPIDTh1133	NameAflibercept	Peptide SequenceSDTGRPFVEMYSEIPEIIHM Full view	Length431	Functional ClassificationIb	DiseaseCancer	BrandEylea	CompanyRegeneron Pharmaceuticals	Physical AppearanceSterile, clear, and colorless to pale yellow solution.	Route of AdministartionIntravitreal injection	CategoryAntineoplastic Agents and Ophthalmics	TargetVascular endothelial growth factor A,Placenta growth factor,Vascular endothelial growth factor B
ID1616	ThPPIDTh1133	NameAflibercept	Peptide SequenceSDTGRPFVEMYSEIPEIIHM Full view	Length431	Functional ClassificationIb	DiseaseCancer	BrandZaltrap	CompanySanofi and Regeneron Pharmaceuticals, Inc.	Physical AppearanceSterile, clear, colorless to pale yellow, non-pyrogenic, preservative-free, solution.	Route of AdministartionIntravenous infusion	CategoryAntineoplastic Agents and Ophthalmics	TargetVascular endothelial growth factor A,Placenta growth factor,Vascular endothelial growth factor B
ID1635	ThPPIDTh1141	NameEpoetin Zeta	Peptide SequenceAPPRLICDSRVLERYLLEAK Full view	Length166	Functional ClassificationIb	DiseaseCancer	BrandRetacrit	CompanyNorbitec	Physical Appearancesolution for injection	Route of AdministartionN.A.	CategoryN.A.	TargetErythropoietin receptor
ID1636	ThPPIDTh1142	NameObinutuzumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIb	DiseaseCancer	BrandGazyva	CompanyGenentech	Physical AppearanceSterile, clear, colorless to slightly brown, preservative free liquid concentrate	Route of AdministartionIntravenous infusion	CategoryAntineoplastic Agents	TargetB-lymphocyte antigen CD20
ID1671	ThPPIDTh1159	NameGemtuzumab ozogamicin	Peptide SequenceLight Chain 1: QIVLT Full view	Length459	Functional ClassificationIIb	DiseaseCancer	BrandMylotarg	CompanyWyeth pharmaceuticals inc	Physical AppearanceSterile, white, preservative-free lyophilized powder	Route of AdministartionIntravenous infusion	CategoryAntineoplastic agents and Immunotoxins	TargetMyeloid cell surface antigen CD33, Low affinity immunoglobulin gamma Fc region receptor III-B, Complement C1r subcomponent, Complement C1q subcomponent subunit A, Complement C1q subcomponent subunit B, Complement C1q subcomponent subunit C, Low affinity immunoglobulin gamma Fc region receptor III-A, Complement C1s subcomponent, High affinity immunoglobulin gamma Fc receptor I, Low affinity immunoglobulin gamma Fc region receptor II-a, Low affinity immunoglobulin gamma Fc region receptor II-b, Low affinity immunoglobulin gamma Fc region receptor II-c
ID1682	ThPPIDTh1163	NameAncestim	Peptide SequenceNA Full view	Length0	Functional ClassificationIb	DiseaseCancer	BrandStemgen	CompanyBiovitrum Ab (publ)	Physical AppearanceNA	Route of AdministartionSubcutaneous	CategoryNA	TargetNA
ID1703	ThPPIDTh1167	NameAtezolizumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIa	DiseaseCancer	BrandTecentriq	CompanyNA	Physical AppearanceNA	Route of AdministartionNA	CategoryNA	TargetNA
ID1708	ThPPIDTh1170	NameBlinatumomab	Peptide SequenceDIQLTQSPASLAVSLGQRAT Full view	Length504	Functional ClassificationIIIc	DiseaseCancer/Genetic	BrandBlincyto	CompanyAMGEN	Physical AppearanceLyophilized Powder for intravenous administration	Route of AdministartionIntravenous	CategoryAntineoplastic Agents, Immunosuppressive Agents, Monoclonal antibodies, Antineoplastic and Immunomodulating Agents	TargetB-lymphocyte antigen CD19; T-cell surface glycoprotein CD3 delta chain
ID1724	ThPPIDTh1174	NameDaratumumab	Peptide SequenceNA Full view	Length0	Functional ClassificationIIIc	DiseaseCancer	BrandDarzalex	CompanyJanssen Biotech, Inc.	Physical AppearanceSolution, concentrate	Route of AdministartionIntravenous	CategoryAntineoplastic Agents	TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1
ID1738	ThPPIDTh1178	NameElotuzumab	Peptide Sequenceheavy chain EVQLVESG Full view	Length689	Functional ClassificationIIIc	DiseaseCancer	BrandNA	CompanyNA	Physical AppearanceInjection, Powder, Lyophilized, for Solution	Route of AdministartionIntravenous	CategoryNA	TargetSLAM family member 7